Drug intelligence / Profile preview

ursodiol

Development stage
Approved
Lead developer
AbbVie
Modality
Small Molecules
Administration
Oral
01

Overview

Ursodiol is a naturally occurring, hydrophilic bile acid that is clinically used to dissolve cholesterol gallstones and treat primary biliary cholangitis. In research sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), ursodiol is being investigated for its potential role in managing obesity and metabolic disorders. The hypothesized mechanism involves the stimulation of energy expenditure through the activation of the G protein-coupled bile acid receptor 1 (TGR5). Activation of TGR5 in metabolic tissues like brown adipose tissue and skeletal muscle triggers an intracellular signaling cascade that increases the activity of type 2 iodothyronine deiodinase (D2). This enzyme converts the inactive thyroid hormone thyroxine (T4) into its active form, triiodothyronine (T3), thereby increasing the body's metabolic rate and thermogenesis.

Brand names
ActigallUrsoUrso 250Urso250Urso-250Urso Forte
Other names
ursodeoxycholic acid3α,7β-dihydroxy-5β-cholan-24-oic acid
02

Targets

GPBAR1DIO2 (Iodothyronine deiodinase type 2)

Beyond the preview

Go deeper on ursodiol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ursodiol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call